Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3776709011 | Product containing only anthraquinone glycoside and salicylic acid in oromucosal dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3776710018 | Anthraquinone glycoside and salicylic acid only product in oromucosal dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4518941000052111 | läkemedel som endast innehåller antrakinonglykosid och salicylsyra, läkemedelsform för munhåla | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only anthraquinone glycoside and salicylic acid in oromucosal dose form (medicinal product form) | räkning av bas i aktiv ingrediens | två | false | Inferred relationship | Some | ||
| Product containing only anthraquinone glycoside and salicylic acid in oromucosal dose form (medicinal product form) | Has manufactured dose form | Oromucosal dose form (dose form) | true | Inferred relationship | Some | ||
| Product containing only anthraquinone glycoside and salicylic acid in oromucosal dose form (medicinal product form) | Is a | Anthraquinone glycoside and salicylic acid only product | true | Inferred relationship | Some | ||
| Product containing only anthraquinone glycoside and salicylic acid in oromucosal dose form (medicinal product form) | Is a | Anthraquinone glycoside- and salicylic acid-containing product in oromucosal dose form | true | Inferred relationship | Some | ||
| Product containing only anthraquinone glycoside and salicylic acid in oromucosal dose form (medicinal product form) | Has active ingredient | Anthraquinone glycoside (substance) | true | Inferred relationship | Some | 2 | |
| Product containing only anthraquinone glycoside and salicylic acid in oromucosal dose form (medicinal product form) | Has active ingredient | Salicylic acid (substance) | true | Inferred relationship | Some | 1 | |
| Product containing only anthraquinone glycoside and salicylic acid in oromucosal dose form (medicinal product form) | Plays role | Antifungal therapeutic role (role) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution | Is a | True | Product containing only anthraquinone glycoside and salicylic acid in oromucosal dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR